Synlett 2023; 34(07): 841-845
DOI: 10.1055/s-0042-1751365
cluster
Chemical Synthesis and Catalysis in India

Synthesis of Linear Tetraquinanes by [3+2] Cycloaddition, Chemoselective Allylation of 7-Ketonorbornene, and Ring-Rearrangement Metathesis as Key Steps

Sambasivarao Kotha
,
Arpit Agrawal
Funded by Council of Scientific and Industrial Research (CSIR), New Delhi, [02(0272)/16/EMR-II].


Abstract

A nine-step synthetic sequence to linear tetraquinanes involving [3+2] cycloaddition, chemoselective allylation, and ring-rearrangement metathesis as key steps is reported. A chemoselective allylation of 7-ketonorbornene was realized for the first time by using indium powder and allyl bromide. By this method, norbornene ketones can be selectively allylated in the presence of a cyclopentanone moiety to give good yields of monoallylated Barbier-type products.

Supporting Information



Publication History

Received: 09 June 2022

Accepted after revision: 28 July 2022

Article published online:
09 September 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References and Notes

    • 1a Kotha S, Sreenivasachary N, Mohanraja K, Durani S. Bioorg. Med. Chem. Lett. 2001; 11: 1421
    • 1b Kotha S, Meshram M, Khedkar P, Banerjee S, Deodhar D. Beilstein J. Org. Chem. 2015; 11: 1833
    • 1c Kotha S, Ravikumar O. Eur. J. Org. Chem. 2016; 3900
    • 1d Kotha S, Chavan AS, Shaikh M. J. Org. Chem. 2012; 77: 482
    • 1e Kotha S, Krishna NG, Halder S, Misra S. Org. Biomol. Chem. 2011; 9: 5597
    • 1f Nagaraju C, Prasad KR. Angew. Chem. Int. Ed. 2014; 53: 10997
    • 1g Datta R, Ghosh S. Beilstein J. Org. Chem. 2018; 14:  2708
    • 1h Kotha S, Meshram M, Aswar VR. Tetrahedron Lett. 2019; 60: 151337
    • 2a Sternbach DD, Hughes JW, Burdi DF, Forstot RM. Tetrahedron Lett. 1983; 24: 3295
    • 2b Wessig P, Müller G. Chem. Rev. 2008; 108: 2051
    • 2c Nicolaou KC, Snyder SA, Montagnon T, Vassilikogiannakis G. Angew. Chem. Int. Ed. 2002; 41: 1668
    • 2d Gregoritza M, Brandl FP. Eur. J. Pharm. Biopharm. 2015; 97: 438
    • 2e Kotha S, Meshram M, Tiwari A. Chem. Soc. Rev. 2009; 38: 2065
    • 2f Kotha S, Chavan AS, Goyal D. ACS Omega 2019; 4: 22261
    • 4a Mehta G, Srikrishna A. Chem. Rev. 1997; 97: 671
    • 4b Kotha S, Fatma A. Asian J. Org. Chem. 2022; 11: e202100595
    • 5a Eaton PE, Mueller RH, Carlson GR, Cullison DA, Cooper GF, Chou T.-C, Krebs EP. J. Am. Chem. Soc. 1977; 99: 2751
    • 5b Eaton PE, Srikrishna A, Uggeri F. J. Org. Chem. 1984; 49: 1728
  • 6 Mehta G, Krishnamurthy N. J. Chem. Soc., Chem. Commun. 1986; 1319
  • 7 Lannoye G, Sambasivarao K, Wehrli S, Cook JM, Weiss U. J. Org. Chem. 1988; 53: 2327
  • 8 Mehta G, Rao KS. J. Org. Chem. 1985; 50: 5537
  • 9 Aebi R, Luef W, Keese R. J. Org. Chem. 1994; 59: 1199
  • 10 Kotha S, Brahmachary E, Sivakumar R, Joseph A, Sreenivasachary N. Tetrahedron Lett. 1997; 38: 4497
  • 11 Chapman NB, Key JM, Toyne KJ. J. Org. Chem. 1970; 35: 3860
    • 12a Knölker H.-J, Jones PG, Wanzl G. Synlett 1998; 613
    • 12b Knölker H.-J. J. Prakt. Chem./Chem.-Ztg. 1997; 339: 304
    • 12c Schmidt A, Knölker H.-J. Synlett 2010; 2207
    • 12d CCDC 2176916 and 2176327 contains the supplementary crystallographic data for compounds 16 and 21b. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures
  • 13 (2′S,3a′R,3b′S,4′S,7′S,7a′R,8a′S)-4′,8a′-Dibromo-2′-(triisopropylsilyl)-2′,3′,3a′,3b′,4′,7′,7a′,8a′-octahydrospiro{[1,3]dioxolane-2,9′-[4,7]methanocyclopenta[a]inden}-8′(1′H)-one (16)Compound 15 (3 g, 8.2 mmol) was stirred in anhyd CH2Cl2 (50 mL). TiCl4 (4.7 g, 24.8 mmol) and allyl(triisopropyl)silane (2.4 g, 12.4 mmol) were added sequentially at rt under an inert atmosphere and the mixture was stirred for 12 h. The reaction was quenched with aq NH4Cl, and the mixture was extracted with CH2Cl2 (×3). The combined organic layer was washed with H2O, dried (Na2SO4), and concentrated. The crude product was purified by column chromatography (silica gel, 10% EtOAc–PE) to give a white solid; yield: 2.5 g (54%); mp 108–110 °C. 1H NMR (400 MHz, CDCl3): δ = 6.25–6.21 (m, 2 H), 4.25–4.15 (m, 2 H), 4.03–3.98 (m, 1 H), 3.94–3.90 (m, 1 H), 3.28–3.25 (m, 1 H), 2.99–2.96 (m, 1 H), 2.75 (dd, J = 5.51, 3.87 Hz, 1 H), 2.68–2.65 (m, 1 H), 2.54–2.49 (m, 1 H), 2.36–2.27 (m, 2 H), 1.97 (dd, J = 7.73, 5.15 Hz, 1 H), 1.584–1.581 (m, 1 H), 1.08–1.05 (m, 21 H). 13C NMR (100 MHz, CDCl3): δ = 215.4, 137.5, 134.6, 125.8, 71.4, 69.3, 66.6, 65.8, 54.6, 54.3, 53.3, 47.8, 47.4, 39.2, 24.8, 19.28, 19.25, 11.46. DEPT135 (100 MHz, CDCl3): CH, CH3 (δ = 137.5, 134.6, 54.6, 54.3, 53.2, 47.4, 24.8, 19.28, 19.25, 11.4); CH2 (δ = 66.6, 65.8, 47.8, 39.2). HRMS (ESI): m/z [M + Na]+ calcd for C24H36Br2NaO3Si: 581.0693; found: 581.0691.
  • 14 Kotha, S.; Jena, K. 2022, unpublished results.
  • 15 (2′S,3a′R,3b′R,4′R,7′S,7a′S,8a′R)-2′-(Triisopropylsilyl)-2′,3′,3a′,3b′,4′,7′,7a′,8a′-octahydrospiro{[1,3]dioxolane-2,9′-[4,7]methanocyclopenta[a]inden}-8′(1′H)-one (17) A solution of 16 (2 g, 3.5 mmol) in anhyd toluene was treated with AIBN (10 mol%). The reaction vessel was covered with aluminum foil to maintain dark conditions. Bu3SnH (3 g, 10.7 mmol) was added dropwise, and the mixture was refluxed at 110 °C for 4 h until the reaction was complete (TLC). The mixture was then cooled and the solvent was evaporated under reduced pressure. The resulting crude mixture was purified by column chromatography (silica gel, 10% EtOAc–PE) to give a pale-green liquid; yield: 962 mg (67%). 1H NMR (400 MHz, CDCl3): δ = 6.29–6.27 (m, 1 H), 6.17–6.14 (m, 1 H), 3.94–3.87 (m, 2 H), 3.84–3.80 (m, 2 H), 3.02–2.99 (m, 1 H), 2.96–2.93 (m, 1 H), 2.91–2.89 (m, 1 H), 2.68–2.64 (m, 1 H), 2.36–2.29 (m, 2 H), 2.08–2.03 (m, 1 H), 1.88–1.85 (m, 2 H), 1.71–1.67 (m, 1 H), 1.60 (s, 1 H), 1.05–1.03 (m, 21 H). 13C (100 MHz, CDCl3): δ = 226.1, 133.9, 133.7, 127.0, 65.1, 64.6, 58.6, 55.0, 51.5, 50.0, 47.0, 42.9, 40.5, 36.2, 24.4, 19.3, 11.5. DEPT135 (100 MHz, CDCl3): CH, CH3 ( δ = 133.9, 133.7, 58.6, 55.0, 51.5, 49.9, 47.0, 42.9, 24.4, 19.3, 11.5); CH2 (δ = 65.1, 64.6, 40.5, 36.2). HRMS (ESI) m/z [M + H]+ calcd for C24H39O3Si: 403.2663; found: 403.2660.
    • 16a Haddad TD, Hirayama LC, Taynton P, Singaram B. Tetrahedron Lett. 2008; 49: 508
    • 16b Nakamura S, Hara Y, Furukawa T, Hirashita T. RSC Adv. 2017; 7: 15582
    • 16c Augé J, Lubin-Germain N, Thiaw-Woaye A. Tetrahedron Lett. 1999; 40: 9245
    • 16d Haddad TD, Hirayama LC, Singaram B. J. Org. Chem. 2010; 75: 642
    • 16e Yoo BW, Choi KH, Lee SJ, Nam GS, Chang KY, Kim SH, Kim JH. Synth. Commun. 2002; 32: 839
    • 16f Araki S, Ito H, Butsugan Y. J. Org. Chem. 1988; 53: 1831
  • 17 (2S,3aR,3bS,4R,7S,7aS,8aR,9S)-9-Allyl-9-hydroxy-2-(triisopropylsilyl)-2,3,3a,3b,4,7,7a,8a-octahydro-4,7-methanocyclopenta[a]inden-8(1H)-one (19) A solution of compound 18 (100 mg, 0.27 mmol) in 3:1 THF–H2O (20 mL) was treated with allyl bromide (267 mg, 2.2 mmol) and In powder (96 mg, 0.83 mmol), and the mixture was stirred at rt for 6 h. When the reaction was complete, the mixture was filtered through Celite and extracted with EtOAc (×3). The combined organic layer was washed with H2O, dried (Na2SO4), and concentrated. The crude product was purified by column chromatography (silica gel, 10% EtOAc–PE) to give a pale-yellow liquid; yield: 104 mg (93%). 1H NMR (500 MHz, CDCl3): δ = 6.16–6.14 (m, 1 H), 6.04–6.02 (m, 1 H), 5.76–5.67 (m, 1 H), 5.16–5.09 (m, 2 H), 3.16–3.13 (m, 1 H), 2.83–2.78 (m, 3 H), 2.46–2.34 (m, 5 H), 2.08–2.04 (m, 1 H), 1.97 (br s, 1 H), 1.86–1.85 (m, 2 H), 1.71–1.67 (m, 1 H), 1.03 (s, 21 H). 13C (125 MHz, CDCl3): δ = 227.6, 134.94, 134.91, 134.7, 119.5, 95.0, 59.1, 56.4, 54.1, 53.5, 48.2, 42.7, 40.6, 37.0, 36.2, 24.4, 19.3, 11.5. DEPT135 (125 MHz, CDCl3): CH, CH3 (δ = 134.94, 134.91, 134.7, 59.1, 56.4, 54.1, 53.5, 48.2, 42.7, 24.4, 19.3, 11.5); CH2 (δ = 119.5, 40.6, 37.0, 36.2). HRMS (ESI) m/z [M + H]+ calcd for C25H41O2Si: 401.2877; found: 401.2876.
  • 18 Preliminary single-crystal X-ray diffraction data for compound 22b are given in the Supporting Information.